Biora Therapeutics Profile Banner
Biora Therapeutics Profile
Biora Therapeutics

@BioraThera

1,625
Followers
59
Following
121
Media
129
Statuses

Biora Therapeutics is a clinical-stage biotech creating innovative smart-pill technology to improve patients' lives.

San Diego, CA
Joined March 2022
Don't wanna be here? Send us removal request.
@BioraThera
Biora Therapeutics
2 years
The goal: delivery of biologics without needles. An oral capsule using liquid jet injection is our solution. Learn more about the technology here: #smartdevice #oraldelivery #biologics #needlefree #drugdelivery $BIOR
29
26
128
@BioraThera
Biora Therapeutics
2 years
Biora Therapeutics Announces Successful Completion of Device Performance Study in #UlcerativeColitis Patients for its Targeted Therapeutics Platform #IBD #colitis #UC #GItwitter $BIOR
7
41
135
@BioraThera
Biora Therapeutics
2 years
Want to understand how our smart device delivers drugs directly to the colon? We made you a video. Learn more about the technology here: #IBD #colitis #UC #ulcerativecolitis #GItwitter #drugdelivery $BIOR
33
27
120
@BioraThera
Biora Therapeutics
2 years
At the Crohn's & Colitis Congress next week, we are presenting the first detailed results from a human study demonstrating device function when administered with food, potentially enabling non-fasted administration. #IBD #colitis #UC #CCCongress23 $BIOR
Tweet media one
12
22
98
@BioraThera
Biora Therapeutics
2 years
$BIOR has no exposure to and does not bank with Silicon Valley Bank.
Tweet media one
27
9
89
@BioraThera
Biora Therapeutics
11 months
$BIOR announces #FDA clearance of IND application for drug/device combination BT-600 targeting treatment of #ulcerativecolitis #IBD #GItwitter
Tweet media one
10
23
89
@BioraThera
Biora Therapeutics
2 years
Sharing topline results today from the second human study in our targeted therapeutics platform for #IBD , showing that our capsule could be administered with food. #drugdelivery $BIOR
6
17
84
@BioraThera
Biora Therapeutics
8 months
$BIOR announces successful completion of single-ascending dose (SAD) cohorts of phase 1 clinical study of BT-600: #IBD #UC #ulcerativecolitis #clinicaltrials
Tweet media one
4
16
81
@BioraThera
Biora Therapeutics
2 years
Biora Therapeutics Announces Issuance of Key Patent for Oral Delivery of GLP-1 Receptor Agonists #drugrelease #oraldelivery #biologics #needlefree #drugdelivery $BIOR
7
9
79
@BioraThera
Biora Therapeutics
1 year
$BIOR announces successful clinical device performance study results for its NaviCap™ targeted oral delivery platform #IBD #UC #ulcerativecolitis #GItwitter
Tweet media one
4
17
77
@BioraThera
Biora Therapeutics
2 years
$BIOR presents data from device performance study with repeat doses in both fasted and fed states at Crohn’s & Colitis Congress #IBD #colitis #UC #CCCongress23
10
14
74
@BioraThera
Biora Therapeutics
2 years
$BIOR Receives Pre-IND Feedback from FDA and Provides Update on Key Programs for 2023 #IBD #colitis #UC #ulcerativecolitis
7
18
72
@BioraThera
Biora Therapeutics
1 year
$BIOR announces submission of IND application to the FDA for BT-600 program #IBD #colitis #UC #ulcerativecolitis #GItwitter
Tweet media one
2
11
69
@BioraThera
Biora Therapeutics
2 years
$BIOR Shares Data from Device Performance Study in #UlcerativeColitis Patients: #IBD #colitis #UC #robotpill #GItwitter
3
15
70
@BioraThera
Biora Therapeutics
2 years
Biora Therapeutics Announces Five Abstracts Accepted at #ACG2022 . Learn more: #oralbiotherapeutics #smartdevice #needlefree #oraldelivery #drugdelivery #biologics $BIOR
3
10
66
@BioraThera
Biora Therapeutics
2 years
Thanks to all who joined the $BIOR Q2 update yesterday. The recorded webcast, latest corporate presentation, and updated investor Q&A are available here:
Tweet media one
3
10
66
@BioraThera
Biora Therapeutics
2 years
We'll be at #CRS2022 next week, presenting two posters on our systemic therapeutics platform for #oraldelivery of #biologics . #smartdevice #drugrelease #needlefree #drugdelivery $BIOR
8
13
66
@BioraThera
Biora Therapeutics
1 year
$BIOR announces new patents for its NaviCap™ targeted oral delivery platform
Tweet media one
8
11
59
@BioraThera
Biora Therapeutics
2 years
6
13
61
@BioraThera
Biora Therapeutics
2 years
Biora Therapeutics to Hold Second Quarter Corporate Update on Aug 15 $BIOR
0
6
59
@BioraThera
Biora Therapeutics
2 years
Biora Therapeutics second quarter update is today. Learn more: $BIOR
4
9
59
@BioraThera
Biora Therapeutics
10 months
$BIOR announces initiation of phase 1 clinical study of BT-600: #clinicaltrial #IBD #ulcerativecolitis #GItwitter
Tweet media one
2
9
59
@BioraThera
Biora Therapeutics
2 years
Biora Therapeutics to participate in the upcoming #BTIG Biotechnology Conference. Learn more: #biotech #pharma $BIOR
5
12
55
@BioraThera
Biora Therapeutics
2 years
$BIOR announces bioavailability results for oral delivery of GLP-1 receptor agonist #oraldelivery #biologics #needlefree #drugdelivery #semaglutide
9
15
57
@BioraThera
Biora Therapeutics
10 months
$BIOR announces new patent for its NaviCap�� Targeted Oral Delivery Platform:
Tweet media one
4
12
55
@BioraThera
Biora Therapeutics
2 years
Dr. Shaoying Nikki Lee (Biora Therapeutics) and Dr. Kathleen Martin (CHI St. Joseph Medical Group) presenting their research on device performance in #UC patients at #ACG2022 this week. View the poster here: #IBD #ulcerativecolitis #GItwitter
Tweet media one
9
8
57
@BioraThera
Biora Therapeutics
2 years
Looking forward to the annual scientific meeting and poster sessions at #ACG2022 next week. #IBD #drugdelivery
4
7
52
@BioraThera
Biora Therapeutics
1 year
$BIOR progresses its BioJet™ systemic oral delivery platform #oraldelivery #biologics #needlefree #drugdelivery
Tweet media one
3
15
51
@BioraThera
Biora Therapeutics
2 years
Biora Therapeutics Shares Presentation of Patient Data Establishing Correlation Between Drug Levels in Colon and Patient Outcomes in Ulcerative Colitis
6
10
56
@BioraThera
Biora Therapeutics
2 years
We'll be presenting next Tuesday at the #HCWCO Global Investment Conference. $BIOR
Tweet media one
2
13
56
@BioraThera
Biora Therapeutics
10 months
$BIOR progresses BioJet™ research collaboration with AstraZeneca: #BioJet #drugdelivery #oraldelivery
Tweet media one
7
11
56
@BioraThera
Biora Therapeutics
2 years
Did you catch our recent poster session at #DDW2022 ? Our team presented proof of concept data on a device for precision #GI #sampling . #microbiome #drugdiscovery $BIOR
7
11
51
@BioraThera
Biora Therapeutics
2 years
Biora Therapeutics to Participate in 12th Annual #PODD2022 Conference #drugdelivery $BIOR
11
9
50
@BioraThera
Biora Therapeutics
1 year
$BIOR presents new data on the BioJet platform at #EASD2023 #oraldelivery #biologics #needlefree #drugdelivery
Tweet media one
4
7
53
@BioraThera
Biora Therapeutics
1 year
$BIOR announces new patents covering its BioJet™ systemic oral delivery platform #drugdelivery #biologics
1
12
47
@BioraThera
Biora Therapeutics
11 months
$BIOR announces new research collaboration for the #BioJet systemic oral #drugdelivery platform #oraldelivery #biologics #needlefree
Tweet media one
7
9
51
@BioraThera
Biora Therapeutics
2 years
$BIOR Announces Sale of #cfDNA Patent Rights to Roche Diagnostics
16
3
51
@BioraThera
Biora Therapeutics
2 years
Biora Therapeutics Licenses Preeclampsia Rule-Out Test for Commercial Development #preeclampsia $BIOR
10
7
51
@BioraThera
Biora Therapeutics
7 months
$BIOR announces new patent covering its BioJet™ Liquid Jet Delivery Technology:
Tweet media one
2
9
52
@BioraThera
Biora Therapeutics
7 months
$BIOR to provide corporate update tomorrow, including results from the SAD portion of BT-600 clinical trial: #earningscall
Tweet media one
2
5
49
@BioraThera
Biora Therapeutics
2 years
Biora Therapeutics announces two posters presenting human data on targeted therapeutics platform at #CCCongress23 #IBD #colitis #UC #ulcerativecolitis #GItwitter $BIOR
27
6
49
@BioraThera
Biora Therapeutics
2 years
7
8
47
@BioraThera
Biora Therapeutics
2 years
Dr. Severine Vermeire's presentation at #DDW2022 shared patient data establishing the correlation between drug levels in the colon and patient outcomes in #UC . It's why we are working on getting more drug to the site of disease for #IBD .
3
10
48
@BioraThera
Biora Therapeutics
2 years
6
8
48
@BioraThera
Biora Therapeutics
2 years
Biora Therapeutics to participate in the upcoming #HCWainwright Global Investment Conference. Learn more: #biotech #pharma $BIOR
11
6
47
@BioraThera
Biora Therapeutics
4 months
$BIOR announces positive clinical trial results for BT-600, demonstrating the NaviCap platform’s ability to deliver therapeutics directly to the colon: #IBD #ulcerativecolitis #NaviCap #clinicaltrial
Tweet media one
3
9
48
@BioraThera
Biora Therapeutics
1 year
$BIOR submits updated IND application for BT-600.
Tweet media one
2
7
45
@BioraThera
Biora Therapeutics
2 months
$BIOR announces positive Nasdaq listing decision:
Tweet media one
6
4
46
@BioraThera
Biora Therapeutics
6 months
$BIOR announces completion of MAD cohorts for #clinicaltrial of BT-600 #NaviCap #ulcerativecolitis
Tweet media one
2
7
45
@BioraThera
Biora Therapeutics
8 months
$BIOR further reduces net debt and monetizes legacy asset
Tweet media one
2
5
47
@BioraThera
Biora Therapeutics
2 years
We envision a world where those affected by #UlcerativeColitis and #CrohnsDisease have better outcomes through therapeutic delivery to the GI tract. #IBD #WorldIBDDay #WorldIBDDay2022
Tweet media one
2
7
44
@BioraThera
Biora Therapeutics
2 years
We’re happy to announce that $PROG is now $BIOR! Please join the live webcast of our first quarter conference call today at 1:30 Pacific / 4:30 PM Eastern.
Tweet media one
4
16
43
@BioraThera
Biora Therapeutics
2 years
Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results $BIOR
2
5
42
@BioraThera
Biora Therapeutics
10 months
$BIOR accelerates debt reduction and raises capital with large institutional investors
Tweet media one
4
5
42
@BioraThera
Biora Therapeutics
1 year
$BIOR continues to monetize legacy diagnostics assets
Tweet media one
10
7
40
@BioraThera
Biora Therapeutics
9 months
$BIOR anticipated catalysts for 2024:
Tweet media one
9
5
39
@BioraThera
Biora Therapeutics
1 year
See our feature today in the San Diego Business Journal: #oraldelivery #biologics #needlefree #drugdelivery $BIOR
Tweet media one
3
11
41
@BioraThera
Biora Therapeutics
1 year
$BIOR to present at H.C. Wainwright 25th Annual Global Investment Conference
Tweet media one
8
8
38
@BioraThera
Biora Therapeutics
1 year
Looking forward to sharing #BioJet preclinical data at #ADA2023 this weekend:
Tweet media one
4
10
39
@BioraThera
Biora Therapeutics
8 months
Insights from this week’s Canaccord Genuity #IBD Symposium, courtesy of $BIOR Chief Medical Officer, Dr. Ariella Kelman. #ulcerativecolitis #GITwitter
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
4
39
@BioraThera
Biora Therapeutics
8 months
Dr. Ariella Kelman, Chief Medical Officer, will participate in the Canaccord Genuity #IBD Symposium on Wednesday:
Tweet media one
0
7
38
@BioraThera
Biora Therapeutics
6 months
$BIOR to present clinical data on device function of the NaviCap™ Oral Delivery Platform at #DDW2024 #NaviCap #GITwitter
Tweet media one
5
5
38
@BioraThera
Biora Therapeutics
1 year
$BIOR appoints Dr. Ariella Kelman as Chief Medical Officer
1
3
34
@BioraThera
Biora Therapeutics
2 years
$BIOR to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update: #earningscall
5
7
36
@BioraThera
Biora Therapeutics
4 months
$BIOR's Dr. Sharat Singh to present an update on BioJet research at the Next Gen Peptide Formulation & Delivery summit on Wednesday:
Tweet media one
5
5
36
@BioraThera
Biora Therapeutics
2 years
Biora Therapeutics Appoints Dr. Bruce Sands as Chair of its Clinical Advisory Board #IBD #colitis #UC #ulcerativecolitis #GItwitter $BIOR
3
6
35
@BioraThera
Biora Therapeutics
1 year
$BIOR presents data on the BioJet™ systemic oral delivery platform at #ADA2023 #oraldelivery #biologics #needlefree #drugdelivery
3
6
33
@BioraThera
Biora Therapeutics
1 month
$BIOR to present at H.C. Wainwright 26th Annual Global Investment Conference on Wed, Sept 11 @ NEW TIME 1:30 PM Eastern. Webcast link:
Tweet media one
4
6
36
@BioraThera
Biora Therapeutics
7 months
$BIOR to report Q4 and full year 2023 financial results and provide corporate update: #earningscall
Tweet media one
2
3
34
@BioraThera
Biora Therapeutics
5 months
$BIOR presents clinical data on device function of the NaviCap™ platform at #DDW2024 #NaviCap #IBD #GITwitter
Tweet media one
2
6
35
@BioraThera
Biora Therapeutics
7 months
$BIOR provides corporate update and reports fourth quarter and full-year 2023 financial results. All performance targets achieved in SAD cohorts of BT-600 clinical trial: #IBD #earningscall #ClinicalTrials
Tweet media one
7
2
34
@BioraThera
Biora Therapeutics
1 month
$BIOR achieves ISO 13485 certification:
Tweet media one
2
5
34
@BioraThera
Biora Therapeutics
1 year
$BIOR to participate in Canaccord Genuity 43rd Annual Growth Conference
Tweet media one
1
6
32
@BioraThera
Biora Therapeutics
2 years
We'll be at #PDAups in October presenting data on the autonomous triggering and injection efficiency of our systemic therapeutics platform for #oraldelivery of #biologics . Learn more:
Tweet media one
1
4
32
@BioraThera
Biora Therapeutics
2 years
Thanks to all who joined the $BIOR Q4 2022 update today. The latest corporate presentation and investor Q&A, which includes a guide to the new program numbers, are available here:
Tweet media one
5
0
31
@BioraThera
Biora Therapeutics
5 months
$BIOR to provide corporate update on Wednesday: #earningscall
Tweet media one
5
6
33
@BioraThera
Biora Therapeutics
2 years
Why is this poster from #DDW2022 important? It suggests multiple inflammatory pathways for #UC , supporting the hypothesis that combination therapy could improve overall patient outcomes.
6
0
32
@BioraThera
Biora Therapeutics
2 years
$BIOR first quarter corporate update and financial results: (formerly $PROG)
Tweet media one
6
4
30
@BioraThera
Biora Therapeutics
2 years
Biora Therapeutics' third quarter corporate update is today. Join the webcast here: $BIOR
15
7
32
@BioraThera
Biora Therapeutics
2 years
Biora Therapeutics to participate in Crohn’s & Colitis Foundation’s IBD Innovate conference $BIOR #IBD #colitis #UC #ulcerativecolitis
11
4
32
@BioraThera
Biora Therapeutics
2 years
Thanks to all who joined the $BIOR Q3 update yesterday. The recorded webcast, latest corporate presentation, and updated investor Q&A are available here:
Tweet media one
17
4
31
@BioraThera
Biora Therapeutics
1 year
$BIOR Q3 corporate update to be held on Nov 13: #earningscall
Tweet media one
6
3
30
@BioraThera
Biora Therapeutics
1 year
$BIOR to Submit Updated IND Application for BT-600
Tweet media one
6
10
31
@BioraThera
Biora Therapeutics
2 years
$BIOR to Report Third Quarter 2022 Financial Results and Provide Corporate Update: #earningscall
14
5
30
@BioraThera
Biora Therapeutics
2 months
$BIOR announces funding agreement with existing investors:
Tweet media one
2
5
31
@BioraThera
Biora Therapeutics
3 months
$BIOR announces supplemental data from clinical trial: #NaviCap #ulcerativecolitis #IBD #clinicaltrials
Tweet media one
6
4
32
@BioraThera
Biora Therapeutics
1 year
Biora Therapeutics to present preclinical data on the BioJet™ systemic oral delivery platform at the 59th annual meeting of the European Association for the Study of Diabetes #EASD2023 #oraldelivery #biologics #needlefree #drugdelivery
7
10
29
@BioraThera
Biora Therapeutics
1 year
$BIOR Q1 2023 corporate update is today. Join the webcast here: … #earningscall
3
5
30
@BioraThera
Biora Therapeutics
1 year
$BIOR provides corporate update and reports second quarter 2023 financial results
Tweet media one
7
6
29
@BioraThera
Biora Therapeutics
3 months
Join $BIOR on Wed, July 17 at 2:00 PM Eastern / 11:00 AM Pacific for a virtual presentation of clinical trial results: #IBD #UC #clinicaltrials
Tweet media one
0
3
30
@BioraThera
Biora Therapeutics
3 months
$BIOR to report Q2 corporate update on Monday, Aug 12 at 4:30 PM Eastern / 1:30 PM Pacific: #earningscall
Tweet media one
6
3
30
@BioraThera
Biora Therapeutics
9 months
Thanks to all who joined us for this morning's #HCWCO fireside chat, which included an update on #NaviCap clinical studies and #BioJet platform development. A replay of the conversation is now available on our website:
Tweet media one
5
5
29
@BioraThera
Biora Therapeutics
2 years
$BIOR Q4 and full-year 2022 corporate update is tomorrow. Join the webcast here: #earningscall
10
3
30
@BioraThera
Biora Therapeutics
9 months
$BIOR announces participation in Canaccord Genuity #IBD symposium on Feb 28:
Tweet media one
4
4
30
@BioraThera
Biora Therapeutics
4 months
$BIOR to host virtual KOL event on results from clinical trial of BT-600 and #NaviCap Targeted Oral Delivery Platform:
Tweet media one
4
4
30